NAMI HelpLine

Early or first-episode psychosis (FEP) refers to when a person first shows signs of losing contact with reality. Acting quickly to connect a person with the right treatment during early psychosis or FEP can be life-changing and radically alter that person’s future. Don’t wait to take the first step and prepare yourself with information by reviewing these tip sheets:

  • Early Psychosis: What’s Going on and What Can You Do?
  • Encouraging People to Seek Help for Early Psychosis
  • Early Intervention: How Can You Support Someone Who is Experiencing Early Psychosis

Effective treatment for schizophrenia is comprehensive and integrates medication, psychotherapy, psychosocial support, and physical health management. Collaboration among psychiatrists, therapists, peer specialists, and primary care providers with the person and their family is key to recovery. Getting treatment as early as possible after symptoms begin can make a big difference in symptom severity and recovery. It is important to work with a health care professional to develop a treatment plan that works best for you.

Coordinated Specialty Care (CSC) is a successful model that combines all the best treatments for people in the first years of psychosis and has been shown to improve outcomes. CSC is available in almost 400 programs at the time of this update. If there is an opportunity to get early support and care, see if one of these innovative programs is right for you or your family member. Learn more and find your closest treatment facility using the resources below:

There is no cure for schizophrenia, but it can be treated and managed in several ways, often in combination:

Recovery while living with schizophrenia is often seen over time, and involves a variety of factors including self-learning, peer support, school and work, and finding the right supports and treatment.

Medication

Medication is an essential part of treating schizophrenia. Antipsychotic medications help reduce symptoms such as delusions, hallucinations, and disorganized thinking. Working closely with a health care professional to find the right medication and dose can make a significant difference in recovery. Because medications can cause side effects, it’s important to have regular check-ins with your health care professional to monitor how you’re feeling and make adjustments as needed.

Types of Antipsychotics

Antipsychotic medications fall into two main groups:

  • First-generation (typical) antipsychotics — are effective in treating psychosis but may cause movement-related side effects like muscle stiffness or tardive dyskinesia.
    • Chlorpromazine (Thorazine)
    • Fluphenazine (Proxlixin)
    • Haloperidol (Haldol)
    • Loxapine (Loxitane)
    • Perphenazine (Trilafon)
    • Thiothixene (Navane)
    • Trifluoperazine (Stelazine)

Long-Acting Injectables (LAIs)

For people who prefer not to take daily oral medications, long-acting injectable (LAI) formulations, given every few weeks or months, are available and can be a convenient and effective option. LAIs help ensure consistent medication levels in the body and can lower the risk of relapse.

Clozapine

It’s important to specifically mention one medication — Clozapine (Clozaril) — a unique second-generation antipsychotic. It is mentioned specifically because it is the only FDA-approved medication for treatment-resistant schizophrenia (TRS). It is also the only FDA-approved medication to reduce suicidality in people living with schizophrenia. Clozapine has additional blood monitoring requirements and side effects, but remains an underutilized resource for people who have not responded to treatment with at least 2 different antipsychotic medications. Clozapine has been shown to be the most effective medication in these cases.

With the help of families and individuals sharing their experiences, NAMI and other advocacy organizations successfully advocated for a reduction in paperwork and process to access clozapine at the FDA in 2025. This announcement signaled the removal of the risk evaluation and mitigation strategy (REMS) process, which eliminates some of the barriers to clozapine use.

Collaborative Medication Management

Finding the right medication can take time. Some people may need to try more than one medication or dose before finding what works best. Shared decision-making, involving the person, the health care professional and the family, to discuss the benefits, side effects, and personal goals, can help make treatment more effective and sustainable over time.

Psychotherapy

Psychotherapy can help people better understand their experiences, manage symptoms, and improve quality of life. Therapy is most effective when combined with medication and support from family and community programs.

  • Cognitive behavioral therapy for Psychosis (CBTp) helps people recognize and reframe distressing thoughts or beliefs related to psychosis. It teaches coping strategies for dealing with voices, suspicious thoughts, and stress. CBTp is particularly helpful for managing residual symptoms that may persist even with medication.
  • Supportive psychotherapyfocuses on helping individuals process their experiences, strengthen coping skills and manage day-to-day challenges. It emphasizes safety, trust and present-focused problem-solving rather than exploring past traumas.
  • Cognitive Enhancement Therapy (CET)works to promote cognitive functioning and confidence in one’s cognitive ability. CET involves a combination of computer-based cognitive exercises designed to improve attention, memory and social cognition. This therapy aims to build confidence and restore functioning in areas affected by schizophrenia. This is an active area of research in the field at this time.

Psychosocial Interventions & Models

People who engage in psychosocial therapeutic interventions often see improvement and experience greater mental stability. Psychosocial interventions enable people to compensate for or eliminate the barriers caused by their schizophrenia and learn to live well. They may be more likely to continue taking their medication and less likely to experience a return or worsening of symptoms. Some of the more common psychosocial interventions include:

  • Assertive Community Treatment (ACT) is a model that provides comprehensive treatment for people with serious mental illnesses, such as schizophrenia. Unlike other community-based programs that connect people with mental health or other services, ACT provides highly individualized services directly to people with mental illness. Professionals work with people with schizophrenia and help them meet the challenges of daily life. ACT professionals also address problems proactively, prevent crises, and ensure medications are taken.
  • Peer support groups, like NAMI Peer-to-Peer and NAMI Connection, encourage people’s involvement in their recovery by helping them work on social skills with others.
  • Individual Placement and Support (IPS) is an evidence-based supported employment approach designed to help people with mental illness locate jobs that match their strengths and interests. Once an individual finds a job, IPS programs provide continuous support to overcome obstacles and succeed in the workplace. IPS teams are a partnership between employment specialists, mental health care providers and the person with mental illness. Based on the person’s choice, family or friends may be included in the team. Employment specialists help individuals identify goals and, together with the team, work toward achieving them. To learn more about IPS visit https://ipsworks.org/.

Complementary Health Approaches

Complementary and alternative health approaches including acupuncture, meditation, and nutrition interventions can be part of a comprehensive treatment plan. For example, Omega-3 fatty acids, commonly found in fish oil, have shown some promise for treating and managing schizophrenia. Some research suggests that omega-3 fatty acids may have supportive benefits for brain health, but more evidence is needed before recommending them as a primary treatment.

For resources and developments in research, visit the National Center for Complementary and Integrative Health.

Additional Concerns

Physical Health. Schizophrenia is associated with other health conditions and behaviors, such as diabetes, cardiovascular problems, lung disease, and smoking. It’s important to work with your health care provider to address your mental and physical health. Some antipsychotic medications also add to risk of obesity and diabetes. Coupled with smoking, this poses critical risks to some people. NAMI developed Hearts+Minds to help people reduce their risk of premature cardiac disease.

GLP-1 medications may also be a useful tool to reduce weight gain and other metabolic health risks in people with mental illness, particularly those taking certain antipsychotic medications. Talk with your health care provider to learn more.

Substance Use. People with schizophrenia are at an increased risk for misusing drugs or alcohol. Substance use can make treatments for schizophrenia less effective, make people less likely to follow their treatment plans, and even worsen symptoms.

 

Reviewed and updated December 2025

NAMI HelpLine is available M-F, 10 a.m. – 10 p.m. ET. Call 800-950-6264,
text “NAMI” to 62640, or email. In a crisis, call or text 988 (24/7).